Live feed09:05:00·23mPRReleasevia QuantisnowNew Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate CancerByQuantisnow·Wall Street's wire, on your screen.MYGN· Myriad Genetics Inc.Health Care
